In vivo direct neuronal conversion as a therapeutic strategy for ischemic stroke  

作　　者：Takashi Irie Taito Matsuda 

机构地区：[1]Department of Stem Cell Biology and Medicine,Graduate School of Medical Sciences,Kyushu University,Fukuoka,Japan [2]Department of Neurology,Neurological Institute,Graduate School of Medical Sciences,Kyushu University,Fukuoka,Japan

出　　处：《Neural Regeneration Research》2025年第8期2309-2310,共2页中国神经再生研究（英文版）

基　　金：supported by JSPS KAKENHI Grant Number JP24K18622(to TI);JSPS KAKENHI Grant Number JP23K18451(to TM)。

摘　　要：Stroke causes neuronal loss,which ultimately results in persistent neurological dysfunction.Globally,stroke was the third-leading cause of death and disability combined in all ages in 2019,after neonatal disorders and ischemic heart disease.In that year,there were 12.2 million incident strokes,101 million prevalent strokes,and 143 million disability-adjusted life-years due to stroke.

关 键 词：NEONATAL DEATH THERAPEUTIC 

分 类 号：R743.3[医药卫生—神经病学与精神病学]